Clinical Trials Browser

Unknown × Interventional × Breast × Clear all

NCT06497660 2025-03-04

Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia

Phase 4 Unknown

Breast Neoplasms

NCT06857747 2025-03-04

Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.

Phase NA Unknown

Breast Neoplasms

NCT06311357 2024-12-27

Percent Weight Change in the Medical Supplement Group of Early Breast Cancer

Phase NA Unknown

Early Stage Breast Cancer

NCT06724835 2024-12-09

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

Phase 1 Unknown

Advanced Breast Cancer

NCT06678230 2024-11-07

Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT06347354 2024-08-27

FLUO

Phase NA Unknown

Breast Neoplasms

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT04354233 2024-08-21

ABLE02

Phase NA Unknown

Breast Neoplasms, Fatigue, Motor Activity

NCT06552650 2024-08-14

Evaluating the Effectiveness of an Early Exercise Program After Breast Reconstruction

Phase NA Unknown

Braest Cancer

NCT06311695 2024-06-24

CESM

Phase 2 Unknown

Breast Neoplasms

NCT06270706 2024-06-12

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06385665 2024-04-26

The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer

Phase NA Unknown

Breast Neoplasms

NCT06172322 2024-04-23

A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer

Phase 1 Unknown

HR Positive/HER-2 Negative Breast Cancer

NCT05084625 2024-04-17

PACED-digitized Support During Adjuvant Endocrine Therapy

Phase NA Unknown

Treatment Adherence and Compliance, Breast Neoplasms

NCT05919212 2024-04-15

DIAMOND

Phase NA Unknown

Breast Neoplasms

NCT06341842 2024-04-02

PROTECT

Phase 2 Unknown

Breast Neoplasms, Cardiotoxicity

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Phase 1 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05812040 2024-03-28

Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge

Phase NA Unknown

Breast Neoplasms, Galactorrhea

NCT06327438 2024-03-25

Effect of Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema: A Randomized Control Trial

Phase NA Unknown

Breast Neoplasms, Lymphedema

NCT06328387 2024-03-25

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT00382070 2024-03-22

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Phase 3 Unknown

3,966 enrolled 12 charts

Breast Neoplasms

NCT03423199 2024-03-22

PATHWAY

Phase 3 Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT06321666 2024-03-20

RESPECT-MI

Phase NA Unknown

Breast Neoplasms

NCT06248918 2024-03-18

WATSOCPAP

Phase NA Unknown

Breast Neoplasms, Motor Activity, Health Behavior

NCT05907941 2024-03-15

ciNPT in Autologous DIEP Flap Breast Reconstruction

Phase NA Unknown

Breast Neoplasms, Surgical Wound Dehiscence

NCT06112158 2024-03-15

Early Diagnosi

Phase NA Unknown

Breast Neoplasms, Health Education, Breast Self-Examination

NCT06176339 2024-03-15

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Phase 2 Unknown

Breast Cancer Female

NCT06313073 2024-03-15

Neoadjuvant Radiotherapy for Breast Cancer

Phase NA Unknown

Breast Neoplasms

NCT06096545 2024-03-13

Axillary Management After Neoadjuvant Chemotherapy

Phase NA Unknown

Breast Neoplasms

NCT03442504 2024-03-12

TEP-FES

Phase NA Unknown

Breast Neoplasms

NCT06300099 2024-03-12

Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block

Phase 4 Unknown

Breast Neoplasms

NCT06164119 2024-03-08

SECCO

Phase NA Unknown

Breast Neoplasms

NCT06251401 2024-03-08

Cardiac Rehabilitation for Breast Cancer Survivors

Phase NA Unknown

Breast Neoplasms, Cardiovascular Diseases

NCT06299852 2024-03-08

Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer

Phase NA Unknown

Breast Neoplasms

NCT03580109 2024-03-06

THERMOEDEME

Phase NA Unknown

BreastGenitourinaryLymphoid

Breast Neoplasms, Lymphedema, Lymphoma, Prostatic Neoplasms

NCT04904653 2024-03-06

The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage

Phase 4 Unknown

Breast Neoplasms

NCT06103318 2024-03-06

ICOgnition

Phase NA Unknown

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT06294041 2024-03-05

INVEST

Phase NA Unknown

Breast Neoplasms

NCT04739670 2024-03-01

BELLA

Phase 2 Unknown

Recurrence, Triple Negative Breast Neoplasms

NCT06288620 2024-03-01

Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer

Phase NA Unknown

Breast Neoplasms

NCT05033925 2024-02-28

Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients

Phase 1/2 Unknown

Breast Neoplasms, Neoplasms

NCT06279806 2024-02-28

The Effect of Mobile Health Application on Posttraumatic Growth in Women Diagnosed With Breast Cancer

Phase NA Unknown

Breast Neoplasms

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT04537286 2024-02-26

First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients

Phase 2 Unknown

Breast Neoplasms

NCT05574881 2024-02-26

Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT05575804 2024-02-26

GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer

Phase 1/2 Unknown

Advanced/ Metastatic Her-2 Positive Breast Cancer

NCT06278298 2024-02-26

Different Level of ECSWT in Post Mastectomy Lymphedema

Phase NA Unknown

Breast Neoplasms, Lymphedema

NCT05949333 2024-02-23

NEUTHREE

Phase 4 Unknown

Breast Neoplasms

NCT06274762 2024-02-23

Visually Impaired Women Model-based Cancer Education and Breast Self-examination

Phase NA Unknown

Breast Neoplasms, Breast Self-Examination

NCT06275321 2024-02-23

Physical Exercise Benefits for Cancer Patients

Phase NA Unknown

Breast Neoplasms, Motor Activity, Neoplasms